Safety of Adjuvant Pembrolizumab (pembro) in a Pooled Analysis of Phase 3 Clinical Trials in Melanoma, Non-Small Cell Lung Cancer (NSCLC), and Renal Cell Carcinoma
ANNALS OF SURGICAL ONCOLOGY(2023)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
ANNALS OF SURGICAL ONCOLOGY(2023)